16 results on '"Melnick, Joel Z"'
Search Results
2. Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis
3. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis
4. EFFECTS OF INTRAVENOUS ABT-870 (IRON (III)-HYDROXIDE OLIGOSACCHARIDE) ON MEAN ARTERIAL PRESSURE AND HEART RATE IN THE ANAESTHETIZED BEAGLE: COMPARISON WITH OTHER IRON-CONTAINING HAEMATINIC AGENTS
5. Antiproteinuric effect of oral paricalcitol in chronic kidney disease
6. Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings
7. Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia
8. Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia
9. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.
10. Modified-Release Calcifediol Effectively Controls Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
11. Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
12. Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis.
13. A Comparison of Dosing Regimens of Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in CKD Stages 3 and 4.
14. Renal citrate metabolism and urinary citrate excretion in the infant rat.
15. Resistance to mineralocorticoids in Wistar-Furth rats.
16. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.